Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing.
Saved in:
| Title: | Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing. |
|---|---|
| Authors: | Kern C; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital (Bern University Hospital), University of Bern, Bern, Switzerland.; Graduate School for Health Sciences, University of Bern, Bern, Switzerland., Schöning V; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital (Bern University Hospital), University of Bern, Bern, Switzerland., Chaccour C; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.; Clínica Universidad de Navarra, Pamplona, Spain.; Ifakara Health Institute, Ifakara, Tanzania., Hammann F; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital (Bern University Hospital), University of Bern, Bern, Switzerland. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2021 Mar 10; Vol. 12, pp. 625678. Date of Electronic Publication: 2021 Mar 10 (Print Publication: 2021). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
